Targeting Growth Factors in Arthritis: A Rational for Restoring the IGF-I Response in Chondrocytes

被引:6
作者
van de Loo, Fons A. [1 ]
Veenbergen, Sharon [1 ]
van den Berg, Wim B. [1 ]
机构
[1] Radboud Univ Nijmegen, Med Ctr, Dept Rheumatol, Rheumatol Res & Adv Therapeut, Nijmegen, Netherlands
关键词
D O I
10.2174/157339708786263861
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The role of growth factors in the pathogenesis of arthritis has received considerably less attention as compared to proinflammatory cytokines in recent years. This is understandable as it is evident that current anti-tumor necrosis factor-(TNF) therapy is efficacious in at least in 60% of the rheumatoid arthritis (RA) patients and when given in combination with methotrexate stops radiological progression of bone erosion. Other proinflammatory cytokines, such as interleukin-1 (IL-1) and IL-17 have also been implicated in the dysregulation of bone and cartilage remodelling characteristic of rheumatoid arthritis (RA) and/or osteoarthritis (OA). The direct effects of anti-cytokine treatment on cartilage pathology are not that easy to determine in humans and it remains to be seen if amelioration of cartilage destruction or better cartilage repair has been accomplished with anti-TNF therapy. A complicating factor is that chondrocytes in RA and OA become non-responsive to insulin-like growth factor-I (IGF-I). IGF-I is the main growth factor for stimulation of chondrocyte proteoglycan and collagen type II synthesis in order to maintain the cartilage matrix integrity. This article reviews our current understanding of the role of IGF-I on cartilage extracellular matrix production and the mechanisms underlying the cause of IGF-I non-responsiveness, and in particular the inhibition of IGF-receptor signalling by suppressor of cytokine signalling (SOCS) proteins. The epigenetic and cytokine-dependent regulation of SOCS expression may give an explanation for the loss of IGF-I signalling in chondrocytes in ageing-related diseases such as OA and RA. Whether IGF-1 is replaceable by other growth factors to maintain the cartilage extracellular matrix will be discussed. It is concluded that in addition to the current use of anti-cytokine therapy in arthritis the IGF-I response of chondrocytes must be restored in order to achieve cartilage matrix repair.
引用
收藏
页码:266 / 276
页数:11
相关论文
共 105 条
[1]   THE EXPRESSION AND REGULATION OF NITRIC-OXIDE SYNTHASE IN HUMAN OSTEOARTHRITIS-AFFECTED CHONDROCYTES - EVIDENCE FOR UP-REGULATED NEURONAL NITRIC-OXIDE SYNTHASE [J].
AMIN, AR ;
DICESARE, PE ;
VYAS, P ;
ATTUR, M ;
TZENG, E ;
BILLAR, TR ;
STUCHIN, SA ;
ABRAMSON, SB .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 182 (06) :2097-2102
[2]   A point mutation of Tyr-759 in interleukin 6 family cytokine receptor subunit gp130 causes autoimmune arthritis [J].
Atsumi, T ;
Ishihara, K ;
Kamimura, D ;
Ikushima, H ;
Ohtani, T ;
Hirota, S ;
Kobayashi, H ;
Park, SJ ;
Saeki, Y ;
Kitamura, Y ;
Hirano, T .
JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 196 (07) :979-990
[3]   Overexpression of active TGF-beta-1 in the murine knee joint: evidence for synovial-layer-dependent chondro-osteophyte formation [J].
Bakker, AC ;
van de Loo, FAJ ;
van Beuningen, HM ;
Sime, P ;
van Lent, PLEM ;
van der Kraan, PM ;
Richards, CD ;
van den Berg, WB .
OSTEOARTHRITIS AND CARTILAGE, 2001, 9 (02) :128-136
[4]   Insulin-like growth factor-1 controls type 2 T cell-independent B cell response [J].
Baudler, S ;
Baumgartl, J ;
Hampel, B ;
Buch, T ;
Waisman, A ;
Snapper, CM ;
Krone, W ;
Brüning, JC .
JOURNAL OF IMMUNOLOGY, 2005, 174 (09) :5516-5525
[5]   LEUKEMIA INHIBITORY FACTOR (LIF) SUPPRESSES PROTEOGLYCAN SYNTHESIS IN PORCINE AND CAPRINE - CARTILAGE EXPLANTS [J].
BELL, MC ;
CARROLL, GJ .
CYTOKINE, 1995, 7 (02) :137-141
[6]   Suppressors of cytokine signaling (SOCS) 1 and SOCS3 interact with and modulate fibroblast growth factor receptor signaling [J].
Ben-Zvi, T ;
Yayon, A ;
Gertler, A ;
Monsonego-Ornan, E .
JOURNAL OF CELL SCIENCE, 2006, 119 (02) :380-387
[7]   Body weight, body composition, and bone turnover changes in patients with spondyloarthropathy receiving anti-tumour necrosis factor α treatment [J].
Briot, K ;
Garnero, P ;
Le Henanff, A ;
Dougados, M ;
Roux, C .
ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (08) :1137-1140
[8]   The role of STATs in transcriptional control and their impact on cellular function [J].
Bromberg, J ;
Darnell, JE .
ONCOGENE, 2000, 19 (21) :2468-2473
[9]   Pathways by which interleukin 17 induces articular cartilage breakdown in vitro and in vivo [J].
Cai, LP ;
Yin, JP ;
Starovasnik, MA ;
Hogue, DA ;
Hillan, KJ ;
Mort, JS ;
Filvaroff, EH .
CYTOKINE, 2001, 16 (01) :10-21
[10]   Nitric oxide inhibits the synthesis of type-II collagen without altering Col2A1 mRNA abundance: Prolyl hydroxylase as a possible target [J].
Cao, M ;
WesterhausenLarson, A ;
Niyibizi, C ;
Kavalkovich, K ;
Georgescu, HI ;
Rizzo, CF ;
Hebda, PA ;
StefanovicRacic, M ;
Evans, CH .
BIOCHEMICAL JOURNAL, 1997, 324 :305-310